[1]
Breccia, M. and Alimena, G. 2014. SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs. Mediterranean Journal of Hematology and Infectious Diseases. 6, 1 (Jan. 2014), e2014003. DOI:https://doi.org/10.4084/mjhid.2014.003.